Healthcare
Wednesday, September 7, 2016
BRIEF-Onxeo S.A. says combination of AsiDNA and PARP inhibitors demonstrates synergistic effect
* Onxeo S.A.: combination of AsiDNA and PARP inhibitors
demonstrates synergistic effect, bypasses genetic restriction
Source text for Eikon:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment